AIMSSNCT07825454
Pilot Study of Hydroxychloroquine for the Treatment of AIMSS
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 2 versions: 2 with changes below.
- Notable Recruitment opened
- Start date changed from estimate of Sep 2026 to Oct 19, 2026
- Site details revised
- Study First Submitted
- Notable: the plan changed
Endpoints
Primary
To evaluate the efficacy of hydroxychloroquine
Timeframe: Day 1 and Week 12
Secondary (8)
Proportion of patients achieving a clinically meaningful improvement
Changes in BPI Worst Pain and Pain Interference scores
Changes in endocrine therapy related quality of life
Changes in grip strength
Patient-reported global impression of change
Show 3 moreShow less
Safety of hydroxychloroquine in this patient population
Tolerability of hydroxychloroquine in this patient population
Adherence to aromatase inhibitor therapy
Arms and interventions
Hydroxychloroquine sulfateExperimental
Hydroxychloroquine sulfate, 400 mg orally once daily
Drugs: Hydroxychloroquine Sulfate (HCQ)
Sites
1 site in 1 country
- Indiana University Melvin and Bren Simon Comprehensive Cancer CenterIndianapolis, Indiana, United States